Found "Public health policy": 1,103 results
Sort by
Relevance

A review of economic evaluation studies in Thailand (in Thai language)

There is an increasing impetus to use economic evaluation to allow more explicit and transparent healthcare priority setting. However, an important question for policy makers is whether it is appropriate and feasible to introduce economic evaluation data into healthcare priority setting or resource allocation decisions. This project systematically

A research development of the system for screening of refractive errors and providing spectacles among pre-primary and primary school children in Thailand

Refractive error is a main cause of visual impairment and blindness around the world. Active screening to identify children with uncorrected refractive error and treating them throught the provision of spectacles is recommend in many countries. However, it is not clear what the best screening stratergy is. Therefore, this study focus on development

The Potential of Provider-initiated Voluntary HIV Counseling and Testing at Healthcare Settings in Thailand

This study aims to evaluate the cost, effectiveness and feasibility of setting up routine offers of HIV counseling and testing in community hospitals. Three methodologies were used : the first was Cluster Randomized Controlled Trials in 16 community hospitals, the second was a cost-effectiveness analysis and the  third was qualitative research to

Cost-Utility Analysis of Acetylcholinesterase inhibitors in the Treatment of Mild to Moderate Alzheimer’s disease (in Thai language)

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

Advanced health biotechnologies in Thailand: redefining policy directions.

For full text, click here http://www.translational-medicine.com/content/pdf/1479-5876-11-1.pdf

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand (2013)

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Waranya Rattanavipapong1, Tanunya Koopitakkajorn1, Naiyana Praditsitthikorn1,2,*, Surakameth Mahasirimongkol3 andYot Teerawattananon1 Summary Purpose There is strong evidence o

Using Financial Mechanisms to Develop a Quality and Outcomes Framework: Issues and Challenges

In the fiscal year of 2014, the National Health Security Office (NHSO) started to disburse its budget based on the Quality and Outcomes Framework (QOF). The QOF is a budget allocation mechanism that incentivizes hospitals to provide quality primary care and achieve results based on the defined indic

Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?

Cetuximab is provided for mCRC patients with positive KRAS wild type, and also head and neck cancer patients as indicated in the Indonesian National Drug Formulary. However, currently, it is also used for indications not specified in the National Drug Formulary. Adding cetuximab to chemothera
10 / Page